The patient agrees to comply with the contraception requirements detailed in the protocol.
SBP \> 10 cmHg
Heart rate \>= 55 bpm
Received for consultation regarding sexual violence at the Medical-Legal Unit (UMJ) for sexual assault and/or rape within 72 hours of the incident occurring.
Affiliated with a social security system
Patient who understands and reads french
Free, informed, and written consent signed by the participant
Impaired consciousness or alertness, amnesia regarding events
Known hypersensitivity to propranolol or treated asthma, even if only occasional
Known interactions with Propranolol (combinations not recommended and combinations to be used with caution) indicated in the summary of product characteristics
Patients who have suffered head trauma within the last year or who have clinical symptoms and neurological sequelae
Patient with myasthenia gravis, with a personal history of psoriasis
Patient wearing contact lenses
Patient with severe liver disease and/or significant renal impairment
Current use of a beta-blocker, regardless of dosage form.
Current use of a drug that has a contraindicated or inadvisable drug interaction with propranolol: bepridil, diltiazem, verapamil, fingolimod.
Addiction: presence of a current disorder related to the use of psychoactive substances.
Current treatment with benzodiazepines
Individuals currently receiving psychotropic treatment such as antipsychotics or antidepressants.
People with known current or past serious psychiatric disorders.
High suicide risk, i.e., participants who responded positively to items 4 or 5 of the C-SSRS suicidal ideation scale or any positive assessment of suicidal behavior in the 6 months prior to selection.
Patients who have previously been diagnosed with PTSD.
